Publications by authors named "A Lankina"

Claim this Profile
C
Cross-herpesvirus immunity of the cytomegalovirus gB/MF59 vaccine response.
A Lankina, A Hargreaves, W T Lui, B Kropff, A Wei

NPJ Vaccines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV's Immunological Achilles' Heel.
Anastasia Lankina, Marta Raposo, Alexander Hargreaves, Claire Atkinson, Paul Griffiths

Vaccines (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of alcohol use data and mortality across a multi-national HIV cohort collaboration.
Suzanne M Ingle, Adam Trickey, Anastasia Lankina, Kathleen A McGinnis, Amy Justice

Alcohol Clin Exp Res (Hoboken)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent Low-Level Variants in a Subset of Viral Genes Are Highly Predictive of Poor Outcome in Immunocompromised Patients With Cytomegalovirus Infection.
Cristina Venturini, Julia M Colston, Oscar Charles, Anastasia Lankina, Timothy Best

J Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread.
A C Gomes, I A Baraniak, A Lankina, Z Moulder, P Holenya

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis